SCHEMBL6715213

SCHEMBL6715213

CCCCC(Cc1ccc(OCCNC(=O)c2ccc(-c3ccc(C(=O)O)cc3)cc2)cc1)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 5/20 0.53
NPC1 O15118 3/20 0.53
RAB9A P51151 2/20 0.53
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
PPARG P37231 3/20 0.52
PTGES O14684 1/20 0.52
ALOX5 P09917 1/20 0.52
PPARA Q07869 1/20 0.52
TSHR P16473 2/20 0.48
USP2 O75604 1/20 0.48
ALOX15 P16050 1/20 0.48
MAPK1 P28482 1/20 0.48
HSD17B10 Q99714 1/20 0.48
MAPT P10636 1/20 0.47
NFKB1 P19838 1/20 0.47
NFKB2 Q00653 1/20 0.47
RELA Q04206 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
FOLH1 Q04609 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6718066 0.94 NPC1 (0.58) NPC1RAB9AMEN1KMT2APPARG
SCHEMBL6715671 0.93 NPC1 (0.52) NPC1RAB9AMEN1KMT2APPARG
SCHEMBL6715805 0.93 PPARG (0.57) NPC1RAB9AMEN1KMT2APPARG
SCHEMBL6715687 0.93 NPC1 (0.52) NPC1RAB9AMEN1KMT2APPARG
SCHEMBL6715291 0.92 PPARG (0.52) RARBNPC1RAB9AMEN1KMT2A
SCHEMBL6715853 0.91 PPARG (0.49) NPC1RAB9AMEN1KMT2APPARG
SCHEMBL6713341 0.91 PPARG (0.49) NPC1RAB9AMEN1KMT2APPARG
SCHEMBL6713188 0.90 PPARG (0.48) NPC1RAB9AMEN1KMT2APPARG
SCHEMBL6714820 0.88 PPARG (0.52) NPC1RAB9AMEN1KMT2APPARG
SCHEMBL6715741 0.87 PPARG (0.51) NPC1RAB9AMEN1KMT2APPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6528525-B1 Amidocarboxylic acid derivatives SANKYO COMPANY, LIMITED (JP) 2003-03-04 US claimed
EP-1026149-A1 AMIDOCARBOXYLIC ACID DERIVATIVES Sankyo Company Limited (JP) 2000-08-09 EP claimed
US-20040006141-A1 Amidocarboxylic acid compounds SANKYO COMPANY, LTD (JP) 2004-01-08 US disclosed
US-6528525-B1 Amidocarboxylic acid derivatives SANKYO COMPANY, LIMITED (JP) 2003-03-04 US disclosed
EP-1026149-A1 AMIDOCARBOXYLIC ACID DERIVATIVES Sankyo Company Limited (JP) 2000-08-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006141-A1 Amidocarboxylic acid compounds NR1H2, AGK, APOL1 RARB 2412/4885NPC1 812/4885RAB9A 3140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.